Atrial Fibrillation Warning Sampling for Target Molecule Research
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective early warning and research tools for predicting the onset of atrial fibrillation, making it difficult to collect clinical samples before and after the condition for in-depth study of targeted treatments.
Innovation Solution
An experimental method involving continuous monitoring with an atrial fibrillation warning system, alarm-triggered sampling, control sampling, data analysis, and targeted treatment research to identify and validate targeting molecules for atrial fibrillation treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If continuous monitoring and alarm-triggered sampling are implemented, then measurement precision and research capability are improved, but device complexity and operational difficulty increase
Solution Approach 1:
The monitoring system is pre-configured with alarm thresholds and sampling protocols before clinical use. The system proactively detects atrial fibrillation onset and automatically triggers sampling at predetermined time points (immediate, 10min, 30min, 60min, 120min), eliminating the need for complex real-time decision-making during sampling operations.
Solution Approach 2:
The system implements continuous feedback loops where monitoring data is constantly analyzed against predefined criteria. When alarm conditions are met, the system provides feedback signals to trigger automated sampling sequences, ensuring precise timing while maintaining operational simplicity through rule-based automation.
2Loss of information
If multiple sampling time points are collected, then data completeness and research value are improved, but loss of time and operational burden increase
Solution Approach 1:
Sampling time points and protocols are predetermined and prepared in advance. The system has pre-established sampling schedules (immediate, 10min, 30min, 60min, 120min post-alarm) that are automatically executed, eliminating the need for complex real-time scheduling and reducing operational time burden.
Solution Approach 2:
The monitoring system automatically manages the entire sampling process without requiring continuous human intervention. It self-monitors for alarm conditions, self-triggers sampling sequences, and self-manages the timing of multiple sample collections, significantly reducing operational burden while maintaining complete data collection.
3Productivity
If automated alarm-triggered sampling is implemented, then productivity and data quality are improved, but device complexity increases
Solution Approach 1:
All sampling parameters, alarm thresholds, and timing protocols are pre-configured before system deployment. The automated system executes predetermined sampling sequences triggered by alarm events, achieving high productivity through simple rule-based automation rather than complex adaptive algorithms.
Solution Approach 2:
The system uses straightforward feedback mechanisms where monitoring data is compared against predefined thresholds. When conditions are met, automated sampling is triggered through simple signal transmission to collection devices, achieving efficient automation without requiring complex control systems or artificial intelligence.
Data Source
AI summary
This application relates to the technical field of medical research and clinical experiments, and provides an experimental method for clinical research of targeting molecules based on an atrial fibrillation warning system. The method includes: continuously monitoring dynamic electrocardiograms of a patient using an atrial fibrillation warning system; when the atrial fibrillation warning system issues an alert indicating imminent atrial fibrillation, immediately collecting blood or other clinical information of the patient; collecting blood or other clinical information of the patient when the patient has not experienced atrial fibrillation and the atrial fibrillation warning system has not issued an alert, to serve as control data; comparing biological indicators during atrial fibrillation occurrence and non-occurrence, and analyzing potential triggering factors and targeting molecules; and based on the identified targeting molecules, conducting targeted treatment research to validate effectiveness of the targeting molecules.